Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Neural Therapeutics Inc. ( (TSE:NURL) ) is now available.
Neural Therapeutics Inc. has completed the acquisition of a 30.75% interest in Hanf.com, a leading German CBD retail store chain. This acquisition is expected to strengthen Neural’s financial fundamentals and provide significant growth prospects in the short, mid, and long term. Hanf.com, with its robust revenue and profit margins, plans to expand its footprint through a franchising model and strategic partnerships, potentially benefiting from future regulatory changes in Germany’s cannabis market.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders.
Average Trading Volume: 52,055
Technical Sentiment Signal: Strong Sell
For an in-depth examination of NURL stock, go to TipRanks’ Overview page.